Merck

Merck opens R&D facility in Ireland

Thursday, September 22, 2011 11:27 AM

More good news for the Irish pharmaceutical industry has come with the official opening of Merck's new 100 million euro R&D facility at Ballydine, Co Tipperary, according to PharmaTimes.

More... »

Merck restructures with job cuts

Tuesday, September 20, 2011 10:23 AM

A few weeks ago, Merck disclosed plans to trim another 12,000 to 13,000 jobs by the end of 2015 in order to save up to $1.5 billion. This is on top of previously announced cuts although efforts to reduce headcount are forcing managers to accelerate their plans, according to Pharmalot.

More... »

Madaus joins Quanterix as CEO

Monday, September 19, 2011 01:06 PM

Quanterix has named Martin D. Madaus, Ph.D. chief executive officer. Madaus, who also retains his position as chairman, brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as president, chairman and CEO of Millipore, acquired by Merck. 

More... »

Pharmaron to host Merck’s R&D laboratory in China

Wednesday, September 14, 2011 02:13 PM

Pharmaron has reported a strategic partnership with Merck Serono. In the framework of this partnership, Pharmaron's new campus in the Beijing economic and technological development area (BDA) will serve as home to Merck Serono's China R&D laboratory.

More... »

Merck, BGI collaborate

Tuesday, September 13, 2011 01:05 PM

Merck and BGI have established a collaboration to focus on the discovery and development of biomarkers and genomic technologies. Under the agreement scientists from Merck and BGI will work closely together to identify and characterize biomarkers with an emphasis on drug discovery, drug development and diagnostics applications across a wide range of therapeutic areas.

More... »

Merck, F-Star ink research agreement

Wednesday, September 7, 2011 02:43 PM

Merck Serono, Darmstadt, Germany, has reported that a research, license and commercialization agreement was signed with F-Star, Vienna, Austria, for the discovery of new antibody-derived therapeutics against inflammatory disease targets, using F-Star's Modular Antibody Technology.

More... »

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

PPD names chief scientific officer of BioDuro

Wednesday, August 17, 2011 11:43 AM

PPD has named Jasmine (Jisong) Cui, Ph.D., chief scientific officer of BioDuro, a PPD Company. Cui will provide scientific leadership to BioDuro's integrated drug discovery services across a range of disease areas and expand its use of novel technologies for small and large molecules and in stem cells and imaging.

More... »

DecisionView to launch enrollment-centric metrics

Monday, August 15, 2011 08:00 AM

Clinical trial enrollment-focused software maker DecisionView is launching what it says will be the first benchmarking effort to focus tightly on enrollment metrics.

More... »

Merck receives subpoena regarding marketing and selling of drugs

Monday, August 8, 2011 01:34 PM

Merck has received a subpoena from the US Department of Justice as part of a criminal investigation into the marketing of various drugs. The feds want info about marketing and selling these drugs - Temodar, which treats brain tumors; the PegIntron hepatitis C treatment; and Intron A, which treats certain cancers - from 2004 through the present, according to Pharmalot.

More... »